Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion type Assertion NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_head.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion evidence source_evidence_literature NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion SIO_000772 25483095 NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion wasDerivedFrom befree-2016 NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.
- NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion wasGeneratedBy ECO_0000203 NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.